PE20051007A1 - INDOLES SUBSTITUTED FOR PIPERIDINE OR HETERODERIVATES THEREOF AS CCR-3 CHEMOKINE MODULATORS - Google Patents
INDOLES SUBSTITUTED FOR PIPERIDINE OR HETERODERIVATES THEREOF AS CCR-3 CHEMOKINE MODULATORSInfo
- Publication number
- PE20051007A1 PE20051007A1 PE2004001117A PE2004001117A PE20051007A1 PE 20051007 A1 PE20051007 A1 PE 20051007A1 PE 2004001117 A PE2004001117 A PE 2004001117A PE 2004001117 A PE2004001117 A PE 2004001117A PE 20051007 A1 PE20051007 A1 PE 20051007A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- heteroderivates
- ccr
- piperidine
- alcoxy
- Prior art date
Links
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 2
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 title 1
- 101710149862 C-C chemokine receptor type 3 Proteins 0.000 title 1
- 102000019034 Chemokines Human genes 0.000 title 1
- 108010012236 Chemokines Proteins 0.000 title 1
- 150000002475 indoles Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 abstract 1
- 102000009410 Chemokine receptor Human genes 0.000 abstract 1
- 108050000299 Chemokine receptor Proteins 0.000 abstract 1
- OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical compound [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE R1 ES ARILO, HETEROARILO SUTITUIDO O NO; R5 ES ALQUILO C1-C6, ALCOXI C1-C6, ACILOXI C1-C6; R6 ES ALQUILO C1-C6, ALCOXI C1-C6, HALOALQUILO C1-C6, ENTRE OTROS; A ES (CICLOALQUIL C3-C6)ALQUILENO C2-C8, ALQUILENO C2-C8 LINEAL O RAMIFICADO, OPCIONALMENTE SUSTITUIDO; B ES ARILO, HETEROARILO; D-E ES CH-CH2-, C=CH-; X-W-V ES N-C=CR7, C=C-NR7; R7 ES H O ALQUILO C1-C6 ; Y ES CF2, O, S(O)N; N ES 0-2; I, J SON 0-2; M ES 0-4. SON COMPUESTOS PREFERIDOS : (1-BENCILPIPERIDIN-4-IL)(4-FLUOROFENIL)AMINA; 1-[2-(1-BENCILPIPERIDIN-4-ILAMINO)FENIL]-2-CLOROBUTAN-1-ONA; 2-ETIL-5-FLUORO-1-{1-[3-(4-FLUOROFENILSULFANIL)PROPIL]PIPERIDIN-4-IL}-1H-INDOL; ENTRE OTROS. SE REFIERE TAMBIEN COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. DUCHOS COMPUESTOS SON MODULADORES DE LA ACTIVIDAD DEL RECEPTOR DE QUIMIOCINA UTILES EN EL TRATAMIENTO Y PREVENCION DE ENFERMEDADES INFLAMATORIAS ASI COMO PATOLOGIAS AUTOINMUNITARIASREFERS TO A COMPOUND OF FORMULA I, WHERE R1 IS ARYL, HETEROARYL, SUBTITUTED OR NOT; R5 IS C1-C6 ALKYL, C1-C6 ALCOXY, C1-C6 ACYLOXY; R6 IS C1-C6 ALKYL, C1-C6 ALCOXY, C1-C6 HALOALKYL, AMONG OTHERS; A ES (C3-C6 CYCLOALKYL) C2-C8 ALKYLENE, LINEAR OR BRANCHED C2-C8 ALKYLENE, OPTIONALLY REPLACED; B IS ARYL, HETEROARYL; D-E IS CH-CH2-, C = CH-; X-W-V ES N-C = CR7, C = C-NR7; R7 IS H O C1-C6 ALKYL; Y IS CF2, O, S (O) N; N IS 0-2; I, J ARE 0-2; M IS 0-4. THE PREFERRED COMPOUNDS ARE: (1-BENZYLPIPERIDIN-4-IL) (4-FLUOROPHENYL) AMINE; 1- [2- (1-BENZYLPIPERIDIN-4-ILAMINO) PHENYL] -2-CHLOROBUTAN-1-ONA; 2-ETHYL-5-FLUORO-1- {1- [3- (4-FLUOROPHENYLSULPHANIL) PROPYL] PIPERIDIN-4-IL} -1H-INDOL; AMONG OTHERS. ALSO REFERS TO PHARMACEUTICAL COMPOSITION AND A PREPARATION PROCEDURE. TWO COMPOUNDS ARE USEFUL MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY IN THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES AS WELL AS AUTOIMMUNE PATHOLOGIES
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03026170 | 2003-11-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20051007A1 true PE20051007A1 (en) | 2005-12-26 |
Family
ID=34610050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2004001117A PE20051007A1 (en) | 2003-11-17 | 2004-11-15 | INDOLES SUBSTITUTED FOR PIPERIDINE OR HETERODERIVATES THEREOF AS CCR-3 CHEMOKINE MODULATORS |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7544806B2 (en) |
| EP (1) | EP1687294B1 (en) |
| JP (1) | JP4825679B2 (en) |
| KR (1) | KR20060127000A (en) |
| CN (1) | CN1882565A (en) |
| AR (1) | AR047123A1 (en) |
| AU (1) | AU2004291297B2 (en) |
| BR (1) | BRPI0416665A (en) |
| CA (1) | CA2545261C (en) |
| IL (1) | IL175678A (en) |
| MX (1) | MXPA06004626A (en) |
| MY (1) | MY143862A (en) |
| NZ (1) | NZ547314A (en) |
| PE (1) | PE20051007A1 (en) |
| RU (1) | RU2382037C2 (en) |
| TW (1) | TW200526622A (en) |
| UY (1) | UY28618A1 (en) |
| WO (1) | WO2005049559A2 (en) |
| ZA (1) | ZA200601800B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE531706T1 (en) | 2005-04-30 | 2011-11-15 | Boehringer Ingelheim Int | NEW PIPERIDINE-SUBSTITUTED INDOLES AND THEIR USE AS CCR-3 MODULATORS |
| CA2667547C (en) | 2006-10-27 | 2014-07-29 | Boehringer Ingelheim International Gmbh | Piperidyl-propane-thiol ccr3 modulators |
| US8148403B2 (en) | 2006-10-27 | 2012-04-03 | Boehringer Ingelheim International Gmbh | Substituted piperidyl-propane-thiols |
| WO2010129351A1 (en) | 2009-04-28 | 2010-11-11 | Schepens Eye Research Institute | Method to identify and treat age-related macular degeneration |
| US10213421B2 (en) | 2012-04-04 | 2019-02-26 | Alkahest, Inc. | Pharmaceutical formulations comprising CCR3 antagonists |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2533924A1 (en) * | 1982-10-05 | 1984-04-06 | Roussel Uclaf | NOVEL 4- (1H-INDOL-3-YL) A-METHYL PIPERIDINE-1-ETHANOL DERIVATIVES, THEIR SALTS, THE PREPARATION PROCESS, THE MEDICINAL APPLICATION AND THE COMPOSITIONS COMPRISING THE SAME |
| US5521197A (en) | 1994-12-01 | 1996-05-28 | Eli Lilly And Company | 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists |
| US5576321A (en) * | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| JP2000516210A (en) * | 1996-07-12 | 2000-12-05 | ロイコサイト，インコーポレーテッド | Chemokine receptor antagonists and methods of use |
| US5962473A (en) | 1996-08-16 | 1999-10-05 | Eli Lilly And Company | Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F |
| WO1998011895A1 (en) | 1996-09-18 | 1998-03-26 | Eli Lilly And Company | A method for the prevention of migraine |
| AR013669A1 (en) * | 1997-10-07 | 2001-01-10 | Smithkline Beecham Corp | COMPOUNDS AND METHODS |
| EA200000768A1 (en) | 1998-01-27 | 2001-06-25 | Эвентис Фармасьютикалз Продактс Инк. | SUBSTITUTED OXOAZAGETEROCYCLIC INHIBITORS OF THE FACTOR Xa |
| ES2165274B1 (en) * | 1999-06-04 | 2003-04-01 | Almirall Prodesfarma Sa | NEW DERIVATIVES OF INDOLILPIPERIDINE AS ANTIHISTAMINIC AND ANTIALERGIC AGENTS. |
| EP1242072A4 (en) | 1999-12-17 | 2004-02-04 | Bristol Myers Squibb Co | Antipsychotic heterocycle compounds |
| AU2001232319B2 (en) * | 2000-02-18 | 2005-01-13 | Meiji Seika Kaisha, Ltd. | Phenoxyalkylamine derivates useful as opioid delta receptor ligands |
| JP2004504396A (en) | 2000-07-21 | 2004-02-12 | ハー・ルンドベック・アクチエゼルスカベット | Indole derivatives useful for treating CNS disorders |
| ES2201899B1 (en) * | 2002-04-01 | 2005-06-01 | Almirall Prodesfarma, S.A. | DERIVATIVES OF AZAINDOLILPIPERIDINE AS ANTIHISTAMINIC AND ANTIALERGIC AGENTS. |
| US7157471B2 (en) * | 2003-08-25 | 2007-01-02 | Boehringer Ingelheim International Gmbh | Haloalkyl- and piperidine-substituted benzimidazole-derivatives |
| ATE531706T1 (en) * | 2005-04-30 | 2011-11-15 | Boehringer Ingelheim Int | NEW PIPERIDINE-SUBSTITUTED INDOLES AND THEIR USE AS CCR-3 MODULATORS |
-
2004
- 2004-11-11 JP JP2006538792A patent/JP4825679B2/en not_active Expired - Fee Related
- 2004-11-11 BR BRPI0416665-5A patent/BRPI0416665A/en not_active IP Right Cessation
- 2004-11-11 KR KR1020067012008A patent/KR20060127000A/en active IP Right Grant
- 2004-11-11 EP EP04818773.6A patent/EP1687294B1/en not_active Not-in-force
- 2004-11-11 WO PCT/EP2004/012775 patent/WO2005049559A2/en active Application Filing
- 2004-11-11 AU AU2004291297A patent/AU2004291297B2/en not_active Ceased
- 2004-11-11 CA CA2545261A patent/CA2545261C/en not_active Expired - Fee Related
- 2004-11-11 CN CNA2004800338440A patent/CN1882565A/en active Pending
- 2004-11-11 RU RU2006121328/04A patent/RU2382037C2/en not_active IP Right Cessation
- 2004-11-11 NZ NZ547314A patent/NZ547314A/en not_active IP Right Cessation
- 2004-11-11 MX MXPA06004626A patent/MXPA06004626A/en active IP Right Grant
- 2004-11-12 MY MYPI20044731A patent/MY143862A/en unknown
- 2004-11-15 UY UY28618A patent/UY28618A1/en not_active Application Discontinuation
- 2004-11-15 PE PE2004001117A patent/PE20051007A1/en not_active Application Discontinuation
- 2004-11-16 TW TW093135011A patent/TW200526622A/en unknown
- 2004-11-16 US US10/990,059 patent/US7544806B2/en active Active
- 2004-11-17 AR ARP040104231A patent/AR047123A1/en not_active Application Discontinuation
-
2006
- 2006-03-02 ZA ZA200601800A patent/ZA200601800B/en unknown
- 2006-05-16 IL IL175678A patent/IL175678A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06004626A (en) | 2006-06-27 |
| US7544806B2 (en) | 2009-06-09 |
| CA2545261A1 (en) | 2005-06-02 |
| CN1882565A (en) | 2006-12-20 |
| EP1687294A2 (en) | 2006-08-09 |
| AU2004291297A1 (en) | 2005-06-02 |
| IL175678A (en) | 2012-08-30 |
| ZA200601800B (en) | 2007-05-30 |
| JP4825679B2 (en) | 2011-11-30 |
| WO2005049559A3 (en) | 2006-04-13 |
| AR047123A1 (en) | 2006-01-11 |
| US20050153979A1 (en) | 2005-07-14 |
| BRPI0416665A (en) | 2007-01-16 |
| UY28618A1 (en) | 2005-06-30 |
| JP2007511480A (en) | 2007-05-10 |
| RU2382037C2 (en) | 2010-02-20 |
| KR20060127000A (en) | 2006-12-11 |
| MY143862A (en) | 2011-07-15 |
| NZ547314A (en) | 2010-02-26 |
| AU2004291297B2 (en) | 2011-06-23 |
| WO2005049559A2 (en) | 2005-06-02 |
| EP1687294B1 (en) | 2014-05-21 |
| IL175678A0 (en) | 2006-09-05 |
| CA2545261C (en) | 2013-07-23 |
| RU2006121328A (en) | 2008-01-10 |
| TW200526622A (en) | 2005-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20081783A1 (en) | NEW 2-AMINOOXAZOLINE AS LIGANDS OF TAAR1 | |
| PE20050874A1 (en) | BENZHIMIDAZOLONE COMPOUNDS THAT HAVE AGONIST ACTIVITY OF THE 5-HT4 RECEPTOR | |
| PE20060777A1 (en) | INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES | |
| PE20081878A1 (en) | COMPOUNDS DERIVED FROM 1- (SUBSTITUTED 4-HYDROXYPHENIL) -4-OL-INDAZOLE | |
| PE20090237A1 (en) | SULFONAMID DERIVATIVES AS SODIUM CHANNELS INHIBITORS | |
| PE20142400A1 (en) | NOVEL COMPOUNDS | |
| RS51137B (en) | Benzimidazole derivative and its use as aii receptor antagonist | |
| PE20011047A1 (en) | AMIDA COMPOUND AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINASES | |
| BRPI0513777A (en) | compound or a salt thereof, pharmaceutical composition, and use of a compound or salt thereof | |
| PE20040898A1 (en) | NEW COMPOUNDS DERIVED FROM PYRIMIDINE | |
| TW200740773A (en) | Diaminopyrimidines as P2X3 and P2X2/3 modulators | |
| AR065794A1 (en) | PYRIMIDODIAZEPINAS REPLACED | |
| AR056870A1 (en) | USE OF TIAZOL COMPOUNDS AS FUNGICIDES AND OBTAINING PROCESSES | |
| PE20090772A1 (en) | BENZIMIDAZOLE DERIVATIVES | |
| PE20120693A1 (en) | HETEROCYCLES COMPOUNDS AS MODULATORS OF PYRUVATE KINASE M2 (PKM2) | |
| PE20060691A1 (en) | SERINAMIDES REPLACED BY BENZOYL | |
| PE20090890A1 (en) | COMPOUNDS DERIVED FROM 1- (2,3-DIHIDROBENZO [1,4] DIOXIN-2-ILMETIL) AZACICLOS AS ANTAGONISTS OF SUPTIPO ADRENORECEPTOR ALFA2C | |
| MX2007005709A (en) | Substituted n-sulfonylaminobenzyl-2-phenoxy acetamide compounds. | |
| PE20120790A1 (en) | 2-MERCAPTOQUINOLIN-3-CARBOXAMIDES SUBSTITUTED AS KCNQ2 / 3 MODULATORS | |
| PE20070490A1 (en) | BENZYMIDAZOLE-2-ONA DERIVATIVE COMPOUNDS SUBSTITUTED WITH PIPERIDINE AS MUSCARINE M1 RECEPTOR AGONISTS | |
| PE20090482A1 (en) | HETEROCYCLIC DERIVATIVES AS ANTAGONISTS OF THE CCR2 RECEPTOR | |
| PE20090622A1 (en) | NEW DERIVATIVES OF BENZIMIDAZOLE REPLACED | |
| PE20030718A1 (en) | LACTAMS AS ANTAGONISTS OF TAQUIQUININS | |
| PE20090620A1 (en) | DERIVATIVES OF 1,2,4,5-TETRAHIDRO-3H-BENZAZEPINEAS, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| MXPA05007115A (en) | Novel cb 1 receptor inverse agonists. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |